Ammonia-Lowering Components for Senescent Cell Removal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for removing senescent cells, which contribute to aging and diseases, often have strong side effects and are not suitable for widespread use.

Innovation Solution

Promoting ammonia excretion in the body using substances like ornithine, citrulline, taurine, and lactulose to reduce the expression of senescent cell markers, thereby removing senescent cells and preventing aging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional anticancer drugs are used to remove senescent cells, then senescent cell removal effectiveness is improved, but side effects become too strong for practical use

Engineering Contradiction:
Improvesenescent cell removal effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent converts the harmful accumulation of ammonia (a waste product of metabolism) into a beneficial mechanism for senescent cell removal. By promoting ammonia excretion through substances like ornithine, citrulline, and lactulose, the patent turns a harmful byproduct into a therapeutic lever to selectively eliminate senescent cells without the severe side effects of traditional anticancer drugs

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the physiological parameter of ammonia levels in the body by introducing substances that alter ammonia metabolism and excretion. This parameter change creates a selective pressure that removes senescent cells while maintaining safety, as the approach modifies metabolic parameters rather than using cytotoxic anticancer agents

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If ammonia excretion is promoted to remove senescent cells, then side effects are reduced, but the mechanism complexity increases

Engineering Contradiction:
Improveside effectsVSAvoidmechanism complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent employs substances that leverage the body's existing ammonia metabolism and excretion pathways. Rather than introducing complex external systems, the invention uses compounds like ornithine and citrulline that naturally participate in the urea cycle, and lactulose that utilizes intestinal bacterial metabolism, allowing the body's own mechanisms to do the work of senescent cell removal

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20250281517A1Senolysis by ammonia-lowering component
Publication Date: 2025.09.11 TAZ INC
  • US20250281517A1 patent drawing
  • US20250281517A1 patent drawing

AI summary

A method of removing senescent cells present in a living body with simpler method with fewer side effects. The method involves a mechanism of maintaining the survival of senescent cells by ammonia which is generated in excess through metabolism and the promotion of ammonia excretion enables the removal of senescent cells. When a component having capable of excreting ammonia is administered to aged mice, the expression level of p21, a marker of senescent cells, significantly decreases. Thus, removing the senescent cells can be achieved by administering a component for removing ammonia.